RemedyRepack recalls Potassium Chloride Micro 10mEq K Extended Release Capsules due to dissolution testing failures. This may affect medication effectiveness. Check NDC 70518-1203-03 and lot numbers for affected products.
“RemedyRepack Potassium Chloride Capsules Recall: Dissolution Issue.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32603-remedyrepack-potassium-chloride-capsules-recall-dissolution-issue. Based on FDA recall #D-0611-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0611-2024%22&limit=1).
The FDA announced on June 26, 2024, that RemedyRepack Inc. is recalling Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules due to CGMP deviations resulting in out-of-specification dissolution levels. The recall affects 142 blister cards distributed nationwide.
Lot #: J0758674-021824, Exp 03/31/2025; J0751898-011424, Exp 01/31/2025
The hazard
The recall is due to CGMP deviations where the product was found to be out of specification for dissolution. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show RemedyRePack Inc. has 35 other recalls on record since February 18, 2015. Other recent recalls include Clindamycin Capsules recalled on April 22, 2025, due to CGMP deviations and another Clindamycin recall on March 24, 2025, also citing CGMP deviations. Similar recent recalls of similar products include Rosuvastatin Tablets recalled on December 31, 2025, for a dissolution issue, Amantadine Capsules recalled on February 13, 2026, for failed dissolution specifications, and Memantine Capsules recalled on March 24, 2026, for failed dissolution specifications.
How to tell if you have this one
Check for the product name 'Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules', 30-count blister card, and NDC 70518-1203-03. Lot numbers J0758674-021824 (exp 03/31/2025) and J0751898-011424 (exp 01/31/2025) are affected.
Brand
RemedyRepack
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the NDC code 70518-1203-03 and lot numbers J0758674-021824 or J0751898-011424 on the blister pack.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0611-2024 (June 26, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0611-2024 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.